As amplification/overexpression of FGFR1, FGFR2, and FGFR3 contributes to progression of lung, gastric, and bladder cancers, respectively, we verified their level of expression in all analyzed cell lines (4, 24, 31–35). The gene discussed is FGFR3; the disease is urinary bladder cancer.